Curtis C Maier (Curtis Maier)

Years Active: 2017-2022
Publications (10 Years): 2

GlaxoSmithKline

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline

United States

Director :: Nonclinical Safety

Publications

Dori R Germolec, Herve Lebrec, Stacey E Anderson, Gary R Burleson, Andres Cardenas, Emanuela Corsini, Sarah E Elmore, Barbara L F Kaplan, B Paige Lawrence, Geniece M Lehmann, Curtis C Maier, Cliona M McHale, L Peyton Myers, Marc Pallardy, Andrew A Rooney, Lauren Zeise, Luoping Zhang, Martyn T Smith
Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification. Environmental health perspectives 130 (10) (2022)
Fiona Sewell, Kathryn Chapman, Jessica Couch, Maggie Dempster, Shawn Heidel, Lise I Loberg, Curtis C Maier, Timothy K Maclachlan, Marque Todd, Jan Willem van der Laan
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use. mAbs 9 (5) (2017)

Curtis C Maier.css-eqlu8i{font-size:small;padding-left:4px;} (Curtis Maier)